Skip to content

Bioalmanac

KLOW

KLOW blend · GLOW with KPV

Preclinical

Status reviewed 20 Aug 2026

Prohibited in sport

GLOW with KPV added: four compounds in one vial at 5:1:1:1. The newest and least studied of the common blends.

Storage

Freeze-dried powder
Refrigerated at 2–8 °C, protected from light.
After mixing
Refrigerated at 2–8 °C and used within about 30 days. A blend cannot be split. A contaminated vial takes every component with it.
Long-term, frozen
Unopened powder is stable at −20 °C or colder.

Reconstitution — 80 mg vial, 2000 mcg dose

On a 1 mL U-100 syringe. Check every figure against your own vial before drawing.

Water addedConcentrationVolume to drawUnitsDoses per vial
1 mL80 mg/mL0.025 mL2.5 units40
2 mL40 mg/mL0.05 mL5 units40
3 mL26.667 mg/mL0.075 mL7.5 units40
5 mL16 mg/mL0.125 mL12.5 units40

Dose ranges reported in sources

Descriptions of what sources report, not recommendations.

GoalRangeFrequencySource
Commonly described community protocol2000–4000 mcgDaily, in courses of 4 to 8 weeksCommunity practice

When to stop

  • Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.
  • An injection site that becomes hot, spreading or produces pus.
  • Any new lump or unexplained persistent symptom.

Not approved anywhere as a mixture or as any of its parts. Sold as a research chemical, with ratios that vary between vendors.

Arithmetic on values you enter. Not medical advice. Not reviewed by a clinician. · bioalmanac.com/peptides/klow

Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.